Hong Fang Song Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 months ago
Hong Fang Song has an estimated net worth of at least $134.0 million*, as of June 4, 2025. They own 3.5 million shares of CGON stock. They have sold 1.5 million shares of CGON stock since 2021, for an estimated $37.6 million.
Hong Fang Song $CGON SEC Form 4 Insider Trading
Hong Fang Song has filed a total of 8 insider trades in $CGON since 2021. Their most recent trade was a sale of 100 shares, made on Sep 03, 2025. Their largest trade was a sale of 700,000 shares, made on Dec 16, 2024. We estimate that they now own 3.5 million shares of $CGON, worth an estimated $96.4 million.
Insider Trading at $CGON
There have been a total of 20 insider trades reported at $CGON since 2021, with 666,472 shares purchased and 1.5 million shares sold. The most active insider traders in $CGON stock have been Corleen M. Roche, Vijay Kasturi, and . The most recent trade was a sale of 69,695 shares reported by Hong Fang Song (None), made on Sep 03, 2025.
History of Insider Stock Trades by Hong Fang Song
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CGON
|
Sale | 100 | Sep 03, 2025 | Sept. 4, 2025, 5 p.m. |
|
CGON
|
Sale | 69,695 | Sep 03, 2025 | Sept. 4, 2025, 5 p.m. |
|
CGON
|
Sale | 30,105 | Sep 03, 2025 | Sept. 4, 2025, 5 p.m. |
|
CGON
|
Sale | 100 | Sep 03, 2025 | Sept. 4, 2025, 5 p.m. |
|
CGON
|
Sale | 700,000 | Dec 16, 2024 | Dec. 17, 2024, 7:03 p.m. |
|
CGON
|
Sale | 424,210 | Aug 29, 2024 | Aug. 30, 2024, 7:18 p.m. |
|
CGON
|
Sale | 226,245 | Aug 29, 2024 | Aug. 30, 2024, 7:18 p.m. |
|
CGON
|
Purchase | 263,157 | Jan 29, 2024 | Jan. 31, 2024, 5:30 p.m. |
$CGON Executives and Stock Owners with Insider Trades
-
Corleen M. Roche, CFO & Secretary
-
Vijay Kasturi, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.